3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Recurrent Ependymoma: new trials by email Literature Review of Recurrent Ependymoma trials Research Report on Recurrent Ependymoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma 5-Azacytidine (5-AZA) group 1, 5-Azacytidine (5-AZA) group 2, 5-Azacytidine (5-AZA) group 3 - Recurrent Ependymoma | Phase 1 | Completed | The University of Texas Health Science Center, Houston | 3 | 2019-02-08 | 2025-04-08 |
| Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors Laboratory Biomarker Analysis, Natural Killer Cell Therapy - Recurrent Childhood Medulloblastoma, Recurrent Ependymoma | Phase 1 | Completed | M.D. Anderson Cancer Center | 12 | 2015-03-17 | 2020-09-02 |
| A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors AdV-tk, valacyclovir, Radiation - Malignant Glioma, Recurrent Ependymoma | Phase 1 | Completed | Candel Therapeutics, Inc. | 8 | 2010-10-01 | 2023-08-25 |
Ependymoma (3) · Astrocytoma (1) · Glioblastoma (1) · Glioma (1) · Medulloblastoma (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Nerve Tissue (3) · Neoplasms, Neuroepithelial (3) · Neuroectodermal Tumors (3) · Glioma (2) · Neuroectodermal Tumors, Primitive (1)
Azacitidine (1) · Prodrugs (1) · Radiation (1) · Radiotherapy (1) · Valacyclovir (1)
Candel Therapeutics, Inc. (1) · M.D. Anderson Cancer Center (1) · The University of Texas Health Science Center, Houston (1)
United States (3)
David I Sandberg, MD (1) · Soumen Khatua (1)
P30CA016672 (1)